- Home
- IPA vs GDL Comparison
IPA vs GDL Comparison
Compare IPA & GDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPA
- GDL
- Stock Information
- Founded
- IPA 1983
- GDL 2006
- Country
- IPA United States
- GDL United States
- Employees
- IPA N/A
- GDL N/A
- Industry
- IPA Biotechnology: Pharmaceutical Preparations
- GDL Investment Managers
- Sector
- IPA Health Care
- GDL Finance
- Exchange
- IPA Nasdaq
- GDL Nasdaq
- Market Cap
- IPA 98.9M
- GDL 93.3M
- IPO Year
- IPA 2017
- GDL N/A
- Fundamental
- Price
- IPA $2.70
- GDL $8.39
- Analyst Decision
- IPA Strong Buy
- GDL
- Analyst Count
- IPA 2
- GDL 0
- Target Price
- IPA $4.00
- GDL N/A
- AVG Volume (30 Days)
- IPA 1.7M
- GDL 11.2K
- Earning Date
- IPA 09-15-2025
- GDL 01-01-0001
- Dividend Yield
- IPA N/A
- GDL 6.02%
- EPS Growth
- IPA N/A
- GDL N/A
- EPS
- IPA N/A
- GDL N/A
- Revenue
- IPA $17,744,713.00
- GDL N/A
- Revenue This Year
- IPA $19.47
- GDL N/A
- Revenue Next Year
- IPA $32.09
- GDL N/A
- P/E Ratio
- IPA N/A
- GDL N/A
- Revenue Growth
- IPA 0.01
- GDL N/A
- 52 Week Low
- IPA $0.27
- GDL $7.65
- 52 Week High
- IPA $2.72
- GDL $8.13
- Technical
- Relative Strength Index (RSI)
- IPA 72.97
- GDL 55.39
- Support Level
- IPA $1.82
- GDL $8.24
- Resistance Level
- IPA $2.12
- GDL $8.40
- Average True Range (ATR)
- IPA 0.20
- GDL 0.07
- MACD
- IPA 0.03
- GDL 0.00
- Stochastic Oscillator
- IPA 98.33
- GDL 95.79
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.
About GDL GDL Fund The of Beneficial Interest
GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.